London-based communications professional. All views expressed are my own, retweets are not an endorsement Author of From the Frontline of History & BloodBond
1 / 2 Personal news klaxon! I have just published my new book: From the Frontline of History - Teddy Campion at war with the Seaforth Highlanders 1895 – 1916, a major new biographical account of the Crete Occupation, Sudan Campaign, Boer War and World War One.
Sponsor spotlight 💡 We are excited to have a several industry #leaders as sponsors for our 16th Annual Healthcare Investor #Conference 2024!
To kickstart the event, @Citi and @Nasdaq are participating in our brand new bonus session 'How to have a successful #IPO on Nasdaq', and are also sponsoring the networking lunch.
The @BabrahamUK Research Campus are kindly sponsoring the tea break.
To close out the event, @CooleyLLP and @ICGplc are sponsors of our networking drinks reception. This is a brilliant opportunity to meet with friends, colleagues and contacts and reflect on the thought provoking #panels of the day!
📺Watch @fderubertis, co-founder and Partner at @medicxi, talk to #OptimumTV about how the market for life science companies moves in #waves, why M&A is more popular than #IPOs right now, and his thoughts on the next big things in the treatment of cancer and autoimmune diseases.
Following the recent re-publication of BloodLine, the concluding book in the Black Tower Trilogy, you can catch up on all three books in the series on special on Kindle today and tomorrow. Link in bio.
As reviewed in The Ileach: “Well written, fast paced and blessed with short chapters, the novel comprises well over 300 pages of intrigue and excitement, allied to a well-conceived plot.”
🎙️Check out Optimum’s latest #podcast episode profiling our client @ResolutionTx . @LaraCampana1, VP of Research Operations outlines the company’s technology based around pro-regenerative #macrophages and its potential to treat #liver disease. Listen to the full episode here: https://t.co/xeDftKWWHL
The first in our ‘Countdown-to-Conference’ mini-series, we join the brilliant @KieranMurphyCEO, former CEO of GE Healthcare and now Chairman of a number of life science companies, including Gamma Biosciences, SPT Labtech and Centiva, and hear his views on the state of play of the life sciences market.
Over the coming months, we will be interviewing a number of the leading experts who are panellists at Optimum’s 16th Annual Healthcare Investor Conference, which will be held at The King’s Fund in London on Thursday October 10th.
The conference is by invitation only, so be sure to register your interest in attending here: https://t.co/75tdXRq59C
Hey @thameswater you need to check this outflow as it seems to be pouring sewerage into the Thames at Rowberry Mead Childens playground between Hammersmith bridge and craven cottage @Feargal_Sharkey have a look👀.
From a $105m #financing for the world’s smallest heart pump, to a phase 1 clinical trial of a novel #glioblastoma drug, here’s what Optimum’s clients have been up to this week! https://t.co/5D8HWfRD3p
#lifesciences#hearthealth#Optimum
📺Watch our latest episode of #OptimumTV, in which @StefanoGulla, CSO of Amsterdam-based @KlingBio_, describes how Kling is creating exceptional antibody-based drugs by interrogating the #immune responses of ‘elite responders’ to #disease.
Commit Bio, spun out from Denmark’s Aarhus University in 2021, has developed a new way of harnessing a part of the body’s immune system – called the complement system – to fight #cancer and #autoimmune disease.
#CommitBio’s CEO Krishna Polu outlines to @Stephen__Adams on #OptimumTV how their #BICE technology is used to “supercharge” conventional antibodies and the progress the company aims to make with its €16m seed financing from @novoholdings and @bioqubeventures.
Optimum's 16th Annual Healthcare Investor Conference is taking place this year on Thursday 10th October! Join us for another wonderful year, where leading speakers from the healthcare and investment communities share their insights on the latest trends and insights on the industry. #OptimumStrategicCommunications #OptimumConference2024
📺Netherlands-based @Xeltis is “building” new blood vessels, using a novel nanofibre polymer, that get gradually transformed into living tissue.
Watch Xeltis’ CEO Eliane Schutte talk about the advantages of their technology, and the Eindhoven company’s ambitions, in our latest edition of #OptimumTV!
🎙 Listen to @jerskillington, CEO of @PoolbegPharma and Tushar Pandey, CEO and Co-founder of @SimBioSys, as they discuss the growing role of #AI in drug development on the latest episode of #OptimumPerspectives!
Stream the full episode here: Optimum Perspectives Podcast – Optimum Strategic Communications (https://t.co/cXtB8J343C) and don't forget to subscribe on your favourite podcast platform so you never miss the latest updates from the #LifeScience community brought to you by #OptimumStrategicCommunications!
Spring conference season is well and truly upon us. What better way to kick it off than hearing our top tips on how to maximise these fantastic networking opportunities!
This episode of #OptimumTV features Optimum’s @NickBastin who shares his insights on how to make the most of the upcoming @Anglonordic, @biotrinity, @LSXLeaders World Congress and @BioCentury's BioEquity conferences. The Optimum team is looking forward to seeing you all there!
Join us for our first episode of #OptimumTV, our new online TV channel where we will be bringing you the latest insights from the world of life science investment.
In this first episode, Optimum’s Stephen Adams asks Eva Haas: “Has spring finally sprung for biotech markets?” After more than two years of difficult conditions, the mood seemed to have perked up over the last few months. So are things now warming up nicely for biotech markets – or is it still freezing out there for companies trying to do deals and raise cash?